NCT06630819 Buccal Infiltration of Different Volumes of Articaine for Extraction.
| NCT ID | NCT06630819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Qassim University |
| Condition | Buccal Infiltration |
| Study Type | INTERVENTIONAL |
| Enrollment | 114 participants |
| Start Date | 2024-11-24 |
| Primary Completion | 2026-05-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 114 participants in total. It began in 2024-11-24 with a primary completion date of 2026-05-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares the effectiveness of two different volumes of buccal infiltration of Articaine for the extraction of mandibular posterior teeth. One group receives buccal infiltration of 1.8 ml of 4% Articaine and the other group receives buccal infiltration of 3.6 ml of 4% Articaine.
Eligibility Criteria
Inclusion Criteria: * All healthy patients (ASA I) or patients with mild systemic disease with no functional limitations (ASA II) * Patients aged ≥ 18 years of age. * Patients requiring extraction of mandibular posterior teeth including grossly decayed tooth, grade I mobile tooth, root stumps and indicated for therapeutic reasons. * Patients not allergic to the drugs or anesthetic agents used in the surgery. Exclusion Criteria: * Acute infection at the extraction site. * Patients indicated for surgical extraction of teeth. * Patients already taking medications affecting pain assessment. * Pregnant patients.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06630819 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Buccal Infiltration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06630819 currently recruiting?
Yes, NCT06630819 is actively recruiting participants. Contact the research team at m.abdulsaleem@qu.edu.sa for enrollment information.
Where is the NCT06630819 trial being conducted?
This trial is being conducted at Buraidah, Saudi Arabia, Buraidah, Saudi Arabia.
Who is sponsoring the NCT06630819 clinical trial?
NCT06630819 is sponsored by Qassim University. The trial plans to enroll 114 participants.